Zwitterionic Metal Chelators for Aqueous Solubility and Targeting
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current metal chelators used in medical, agricultural, and chemical processes lack solubility in aqueous environments and exhibit non-specific interactions, leading to reduced efficacy and increased toxicity in diagnostic imaging and therapeutic applications.
Innovation Solution
Development of zwitterionic metal chelators with enhanced solubility and minimized non-specific interactions, incorporating targeting vectors like cRGD, PSMA-617, and FAPI, which improve signal-to-background ratios and therapeutic windows by facilitating efficient clearance from the body.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If common metal chelators (DOTA, PyC3A, macropa) are used, then metal binding stability is achieved, but aqueous solubility is insufficient and non-specific interactions increase
Solution Approach 1:
The patent modifies the chemical structure of metal chelators by introducing zwitterionic groups (containing both positive and negative charges) to alter the physicochemical parameters of the chelator. This structural modification changes the charge distribution and hydrophilicity, thereby improving aqueous solubility and reducing non-specific interactions while maintaining metal binding stability through the preserved chelating functional groups.
Solution Approach 2:
The invention creates composite chelator structures that combine traditional metal-chelating moieties (such as macrocyclic rings and carboxylate groups) with zwitterionic components. This composite approach integrates the metal-binding capability of conventional chelators with the solubility-enhancing and interaction-reducing properties of zwitterionic groups, achieving both stable metal complexation and improved biodistribution.
2Measurement precision
If metal chelators are used in diagnostic imaging, then disease detection at cellular level is enabled, but background signal increases due to non-specific uptake
Solution Approach 1:
By modifying the charge characteristics of metal chelators to zwitterionic forms, the patent alters their biodistribution patterns. The balanced positive and negative charges reduce electrostatic interactions with non-specific tissue components, thereby decreasing background uptake and improving the signal-to-background ratio for disease detection while preserving the ability to target specific cellular pathways.
3Productivity
If metal chelators are used in radiotherapy, then therapeutic effect is achieved, but toxicity increases due to accumulation in off-target tissues
Solution Approach 1:
The introduction of zwitterionic groups modifies the pharmacokinetic parameters of radiotherapeutic metal chelators, enhancing their hydrophilicity and reducing protein binding. This leads to improved renal clearance and reduced accumulation in off-target tissues, thereby maintaining therapeutic efficacy while minimizing toxicity to healthy organs.
Solution Approach 2:
The patent effectively extracts or removes the problematic non-specific binding properties from metal chelators by replacing traditional hydrophobic or cationic groups with zwitterionic moieties. This extraction of harmful interaction characteristics allows the chelators to maintain their metal-binding and therapeutic functions while eliminating the tendency to accumulate in non-target tissues.
4Adaptability or versatility
If carboxylic acid arms are replaced with targeting vectors, then targeting capability is improved, but chelating properties are compromised
Solution Approach 1:
The patent segments the chelator structure into distinct functional modules: a metal-chelating core that retains the essential coordination chemistry for stable metal binding, and separate zwitterionic or targeting vector moieties attached through linkers. This segmentation allows the targeting functionality to be added without interfering with the metal-binding site, preserving chelating properties while enhancing targeting capability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Zwitterionic metal chelators enhance the solubility of metal complexes in aqueous environments, reduce non-specific interactions, and improve imaging and therapeutic outcomes by increasing signal-to-background ratios and therapeutic windows, while allowing for efficient clearance from the body.
Implementation Method 1
zwitterionic metal chelators have desirable properties that maximize solubility in aqueous environments
Implementation Method 2
minimize non-specific interactions
Data Source
AI summary
The present invention relates to zwitterionic metal chelators and their use as imaging, diagnostic, chemical processing, and treatment agents. These zwitterionic metal chelators have desirable properties that maximize solubility in aqueous environments, minimize non-specific interactions, and retain the ability to target thus resulting in an improved performance in a variety of medical, agricultural, and chemical processes. In in vivo and medical applications, zwitterionic metal chelators improve the signal-to-background ratio and therapeutic window as compared to other metal chelators while retaining high stability.